Benfotiamine reduces pathology and improves muscle function in mdx mice.
Keryn G. Woodman, Chantal A. Coles, Su L Toulson, Elizabeth M. Gibbs, Matthew Knight, Matthew McDonagh, Rachelle H. Crosbie-Watson, Shireen R. Lamandé, Jason D. White
Benfotiamine reduces dystrophic pathology and improves muscle function in mdx mice by decreasing inflammation and increasing utrophin/dystrophin complex expression.
bioRxiv · Mar 25, 2018 · PreprintPhysiology